Figure 10.Proposed mechanism for how the axis involving lncRNA CRART16, miR-122-5p, and c-Fos drives angiogenesis and bevacizumab resistance in gastric cancer.
Figure 10 — LncRNA CRART16/miR-122-5p/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression | Aging
